One third of the global population has been acutely infected with hepatitis B virus (HBV);
less than 1% of patients with acute infection will develop fulminant hepatitis. 1 Approximately …

Hepatitis B e antigen (HBeAg)-negative chronic hepatitis B evolves in the natural history of
chronic hepatitis B virus (HBV) infection linked with selection of nonproducing HBeAg but …

The hepatitis B virus (HBV) genotype was determined in a total of 121 plasma samples
collected in France and the US from patients chronically infected with HBV. HBV genotype A …

Background The risk of hepatocellular carcinoma (HCC) increases with increasing level of
hepatitis B virus (HBV) in serum (viral load). However, it is unclear whether genetic …

Background Adefovir dipivoxil, a nucleotide analogue, demonstrated clinically significant
antiviral activity in patients with chronic hepatitis B in phase 1 and 2 clinical trials. Methods …

Background & Aims: There is a paucity of data on hepatitis B virus (HBV) DNA levels and
histologic lesions in patients with chronic HBV (CHBV) infection and persistently normal …

Background & Aims: The aim of this study was to investigate if the variable outcome of
chronic hepatitis B may be related to hepatitis B virus (HBV) genotype. Methods: The clinical …

This placebo controlled, double‐blind study evaluated the efficacy and safety of lamivudine
in patients with hepatitis B e antigen (HBeAg)‐negative/hepatitis B virus (HBV) DNA …

The nucleotide at position 1858 of hepatitis B virus has importance in chronic hepatitis B
(HB) because a cytosine at nt 1858 effectively prevents virus escape through the precore …

Virus load and liver damage, as measured by quantitative polymerase chain reaction and
histology activity index, were related to genotype and core promoter mutations in 43 chronic …